|
|
.
See Category: Diseases of the nervous system
ICD-10 (CM) Code and Descriptor
|
G89.3 |
Neoplasm related pain (acute) (chronic)
|
G893 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 12.27%
|
14.79%
|
17.20%
|
14.44%
|
10.97%
|
8.13%
|
5.84%
|
4.24%
|
2.95%
|
2.23%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G89.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
15,089
|
15,226
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
6,917
|
6,994
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,721
|
4,727
|
|
80053
|
COMPREHEN METABOLIC PANEL |
4,150
|
4,152
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,239
|
3,283
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
2,920
|
9,980
|
|
J1170
|
HYDROMORPHONE INJECTION |
2,064
|
6,878
|
|
96374
|
THER/PROPH/DIAG INJ IV PUSH |
1,849
|
1,855
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
1,810
|
2,865
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,654
|
9,124
|
|
83735
|
ASSAY OF MAGNESIUM |
1,527
|
1,538
|
|
80048
|
METABOLIC PANEL TOTAL CA |
1,228
|
1,235
|
|
96376
|
TX/PRO/DX INJ SAME DRUG ADON |
1,216
|
2,515
|
|
J2270
|
MORPHINE SULFATE INJECTION |
1,178
|
2,132
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
1,158
|
1,441
|
|
93005
|
ELECTROCARDIOGRAM TRACING |
1,157
|
1,214
|
|
99284
|
EMERGENCY DEPT VISIT MOD MDM |
1,106
|
1,107
|
|
99285
|
EMERGENCY DEPT VISIT HI MDM |
1,073
|
1,074
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1,049
|
89,033
|
|
96361
|
HYDRATE IV INFUSION ADD-ON |
929
|
2,766
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G89.3 related to the following DRG Codes:
947-948
|
